Screade® | The FDA gives the green light to the first gene therapy for

BusinessElectronics

The FDA gives the green light to the first gene therapy for deafness - NPR

The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.